Beneficial response to rituximab in refractory Felty syndrome

被引：16

作者：

Weinreb, N ^{[1
]}

Rabinowitz, A ^{[1
]}

Dellaripa, PF ^{[1
]}

机构：

[1] Lahey Clin Fdn, Dept Rheumatol, Burlington, MA 01803 USA

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2006年 / 12卷 / 01期

关键词：

D O I：

10.1097/01.rhu.0000200326.17729.76

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：48 / 48

页数：1

共 4 条

[1] Felty's syndrome [J].

Balint, GR ;

Balint, PV .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (05) :631-645

[2] Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].

Edwards, JCW ;

Szczepanski, L ;

Szechinski, J ;

Filipowicz-Sosnowska, A ;

Emery, P ;

Close, DR ;

Stevens, RM ;

Shaw, T .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581

[3] Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus [J].

Hellmich, B ;

Csernok, E ;

Schatz, H ;

Gross, WL ;

Schnabel, A .

ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :2384-2391

[4] Lack of efficacy of rituximab in Felty's syndrome [J].

Sordet, C ;

Gottenberg, JE ;

Hellmich, B ;

Kieffer, P ;

Mariette, X ;

Sibilia, J .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (02) :332-333

← 1 →